Production (Stage)
TG Therapeutics, Inc.
TGTX
$34.57
$0.330.96%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 5.06M | 23.33M | 3.88M | 6.88M | -10.71M |
| Total Depreciation and Amortization | 8.00K | 9.00K | 11.00K | 19.00K | 29.00K |
| Total Amortization of Deferred Charges | 352.00K | 356.00K | 467.00K | 692.00K | 692.00K |
| Total Other Non-Cash Items | 14.41M | 11.40M | 15.26M | 8.61M | 7.85M |
| Change in Net Operating Assets | -48.54M | -60.74M | -31.83M | -10.67M | -6.07M |
| Cash from Operations | -28.72M | -25.64M | -12.21M | 5.54M | -8.21M |
| Capital Expenditure | -25.00K | -21.00K | -24.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -12.91M | 15.81M | -9.31M | 1.77M | -9.26M |
| Cash from Investing | -12.93M | 15.79M | -9.33M | 1.77M | -9.26M |
| Total Debt Issued | -- | 0.00 | 244.82M | -- | -- |
| Total Debt Repaid | -- | 0.00 | -107.55M | -- | -- |
| Issuance of Common Stock | 21.00K | 570.00K | 199.00K | 135.00K | 10.00K |
| Repurchase of Common Stock | -6.12M | -6.61M | -2.15M | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -31.00K | -858.00K | -- | -- |
| Cash from Financing | -6.10M | -6.07M | 134.45M | 135.00K | 10.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -47.75M | -15.93M | 112.92M | 7.44M | -17.45M |